| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.072 | 0.1 |